Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0G87
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,040
Award facts
- Contract value 100% obligated
- $4,039.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,040 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued December 3, 2025, represents one of multiple orders placed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The broader PPV-G GEN V program, valued at $30.3 billion, establishes multiple regional prime vendor contractors to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's underlying IDC, awarded November 13, 2025, carries a $500 million ceiling value through December 31, 2036, with a 30-month base period and three optional 30-month extension periods.
Under this delivery order structure, DMS Pharmaceutical Group supplies an extensive portfolio of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's product offerings encompass oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals designed to support military healthcare operations globally. No set-aside designation was applied to this award, demonstrating the company's competitive capability in unrestricted federal procurement. The firm fixed-price delivery order structure enables the Defense Logistics Agency to procure required pharmaceutical inventory efficiently while leveraging DMS Pharmaceutical Group's established supply chain capabilities and demonstrated performance across the Department of Defense's medical supply requirements.
Quick answers
Who was awarded contract SPE2DU26F0G87?
SPE2DU26F0G87 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DU26F0G87 worth?
The government has obligated $4,040 on SPE2DU26F0G87.
Is contract SPE2DU26F0G87 an order under another contract?
Yes. SPE2DU26F0G87 is a delivery order under SPE2DU25D9815, an indefinite delivery contract.
Was contract SPE2DU26F0G87 competed?
The extent of competition for SPE2DU26F0G87 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award